Suppr超能文献

按年龄分层的转移性肾细胞癌患者的临床特征和预后因素。

Clinical features and prognostic factors of patients with metastatic renal cell carcinoma stratified by age.

机构信息

Department of Nephrology, Henan Provincial People's Hospital, Henan Provincial Key Laboratory of Kidney Disease and Immunology, Zhengzhou University People's Hospital, Henan University People's Hospital, Zhengzhou 450003, Henan, China.

Department of Hepatobiliary Surgery, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Henan University Peoples Hospital, Zhengzhou 450003, Henan, China.

出版信息

Aging (Albany NY). 2021 Mar 3;13(6):8290-8305. doi: 10.18632/aging.202637.

Abstract

This study compared the clinicopathological characteristics and survival of patients with metastatic renal cell carcinoma (mRCC) stratified by age to identify clinical features and prognostic factors. Patients with renal cell carcinoma (RCC) between 2010 and 2015 were identified from the Surveillance, Epidemiology and End Results database. Age was an independent prognostic factor for patients with RCC, mRCC, mRCC of clear cell renal cell carcinoma and lung-related metastases. There were many significant differences between the younger and older groups, including differences in marital status, race, sex, year of diagnosis, histology grade, laterality, T stage, N stage, tumor size, type of treatment, including surgery, radiation or chemotherapy, and pattern of organic metastasis to the liver, lung, or brain (P<0.05). Moreover, different natural metastasis patterns and poorer overall survival were observed in the older group compared with the younger group (P<0.05). Parameters, including marital status, sex, year of diagnosis, histological grade, N stage, surgery, chemotherapy, lung metastasis and liver metastasis, were independent prognostic factors for elderly patients (P<0.05). Age plays a significant role in mRCC, and elderly patients with mRCC are a special group of individuals whose clinical characteristics and prognostic factors are different from those of younger patients; therefore, these patients require special attention.

摘要

本研究通过对年龄分层的转移性肾细胞癌(mRCC)患者的临床病理特征和生存情况进行比较,以确定临床特征和预后因素。从监测、流行病学和最终结果数据库中确定了 2010 年至 2015 年期间患有肾细胞癌(RCC)的患者。年龄是 RCC、mRCC、透明细胞肾细胞癌 mRCC 和与肺相关的转移患者的独立预后因素。年轻组和老年组之间存在许多显著差异,包括婚姻状况、种族、性别、诊断年份、组织学分级、侧别、T 分期、N 分期、肿瘤大小、治疗类型(包括手术、放疗或化疗)以及肝、肺或脑的有机转移模式(P<0.05)。此外,与年轻组相比,老年组的自然转移模式不同,总体生存率较差(P<0.05)。婚姻状况、性别、诊断年份、组织学分级、N 分期、手术、化疗、肺转移和肝转移是老年患者的独立预后因素(P<0.05)。年龄在 mRCC 中起着重要作用,老年 mRCC 患者是一个特殊的群体,其临床特征和预后因素与年轻患者不同;因此,这些患者需要特别关注。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3de/8034891/3cb8368b5e4a/aging-13-202637-g001.jpg

相似文献

1
Clinical features and prognostic factors of patients with metastatic renal cell carcinoma stratified by age.
Aging (Albany NY). 2021 Mar 3;13(6):8290-8305. doi: 10.18632/aging.202637.
4
Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
BJU Int. 2012 Jul;110(1):76-83. doi: 10.1111/j.1464-410X.2011.10690.x. Epub 2011 Nov 1.
5
Patterns of distant metastases in patients with clear cell renal cell carcinoma--A population-based analysis.
Cancer Med. 2021 Jan;10(1):173-187. doi: 10.1002/cam4.3596. Epub 2020 Nov 28.
6
Prognostic analysis of postoperative clinically nonmetastatic renal cell carcinoma.
Cancer Med. 2020 Feb;9(3):959-970. doi: 10.1002/cam4.2775. Epub 2019 Dec 16.
8
Young age is independent prognostic factor for cancer-specific survival of low-stage clear cell renal cell carcinoma.
Urology. 2009 Jan;73(1):137-41. doi: 10.1016/j.urology.2008.08.460. Epub 2008 Oct 31.
10

引用本文的文献

4
Establishment and validation of a prognostic nomogram for patients with renal cell carcinoma based on SEER and TCGA database.
Transl Cancer Res. 2023 Jun 30;12(6):1411-1421. doi: 10.21037/tcr-22-2692. Epub 2023 Jun 9.
7
A Simple-To-Use Nomogram for Predicting Early Death in Metastatic Renal Cell Carcinoma: A Population-Based Study.
Front Surg. 2022 Mar 22;9:871577. doi: 10.3389/fsurg.2022.871577. eCollection 2022.

本文引用的文献

2
Estimating the Lifespan of Elderly Patients With Cerebral Metastases from Kidney Cancer.
In Vivo. 2020 May-Jun;34(3):1321-1324. doi: 10.21873/invivo.11908.
3
Epigenetic remodelling shapes inflammatory renal cancer and neutrophil-dependent metastasis.
Nat Cell Biol. 2020 Apr;22(4):465-475. doi: 10.1038/s41556-020-0491-2. Epub 2020 Mar 23.
6
Increasing kidney cancer incidence and survival in Estonia: role of age and stage.
Acta Oncol. 2019 Jan;58(1):21-28. doi: 10.1080/0284186X.2018.1512158. Epub 2018 Oct 3.
7
Role of metastasis-directed treatment in kidney cancer.
Cancer. 2018 Sep 15;124(18):3641-3655. doi: 10.1002/cncr.31341. Epub 2018 Apr 24.
8
Marital status and survival in patients with renal cell carcinoma.
Medicine (Baltimore). 2018 Apr;97(16):e0385. doi: 10.1097/MD.0000000000010385.
9
Racial, Ethnic, and Gender Disparities in Health Care Access and Use Among U.S. Adults With Serious Psychological Distress.
Psychiatr Serv. 2018 May 1;69(5):517-522. doi: 10.1176/appi.ps.201700221. Epub 2018 Feb 1.
10
Cancer statistics, 2018.
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验